JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

Search

Thermo Fisher Scientific Inc

Avatud

SektorTervishoid

566.86 1.77

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

553.91

Max

571.44

Põhinäitajad

By Trading Economics

Sissetulek

100M

1.6B

Müük

491M

11B

P/E

Sektori keskmine

31.148

37.461

Dividenditootlus

0.3

Kasumimarginaal

14.878

Töötajad

125,000

EBITDA

1.1B

2.8B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+10.37% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.30%

2.33%

Järgmine aktsia dividendi kuupäev (ex-date)

12. dets 2025

Turustatistika

By TradingEconomics

Turukapital

52B

205B

Eelmine avamishind

565.09

Eelmine sulgemishind

566.86

Uudiste sentiment

By Acuity

29%

71%

74 / 373 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Thermo Fisher Scientific Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. okt 2025, 20:49 UTC

Tulu

Correction to Thermo Fisher Article on Oct. 22

22. okt 2025, 10:28 UTC

Tulu

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23. juuli 2025, 10:33 UTC

Tulu

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25. juuni 2025, 21:19 UTC

Omandamised, ülevõtmised, äriostud

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28. mai 2025, 14:02 UTC

Omandamised, ülevõtmised, äriostud

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23. apr 2025, 10:33 UTC

Tulu

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

22. okt 2025, 10:01 UTC

Tulu

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22. okt 2025, 10:00 UTC

Tulu

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22. okt 2025, 10:00 UTC

Tulu

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22. okt 2025, 10:00 UTC

Tulu

Thermo Fisher 3Q Rev $11.12B >TMO

22. okt 2025, 10:00 UTC

Tulu

Thermo Fisher 3Q Net $1.62B >TMO

22. okt 2025, 10:00 UTC

Tulu

Thermo Fisher 3Q EPS $4.27 >TMO

2. sept 2025, 12:15 UTC

Omandamised, ülevõtmised, äriostud

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2. sept 2025, 12:08 UTC

Omandamised, ülevõtmised, äriostud

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2. sept 2025, 12:08 UTC

Omandamised, ülevõtmised, äriostud

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2. sept 2025, 12:04 UTC

Omandamised, ülevõtmised, äriostud

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2. sept 2025, 12:03 UTC

Omandamised, ülevõtmised, äriostud

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2. sept 2025, 12:03 UTC

Omandamised, ülevõtmised, äriostud

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2. sept 2025, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23. juuli 2025, 10:00 UTC

Tulu

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23. juuli 2025, 10:00 UTC

Tulu

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23. juuli 2025, 10:00 UTC

Tulu

Thermo Fisher 2Q Net $1.62B >TMO

23. juuli 2025, 10:00 UTC

Tulu

Thermo Fisher 2Q EPS $4.28 >TMO

23. juuli 2025, 10:00 UTC

Tulu

Thermo Fisher 2Q Rev $10.85B >TMO

14. juuli 2025, 16:12 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14. juuli 2025, 15:06 UTC

Omandamised, ülevõtmised, äriostud

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28. mai 2025, 13:47 UTC

Omandamised, ülevõtmised, äriostud

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23. apr 2025, 10:01 UTC

Tulu

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23. apr 2025, 10:00 UTC

Tulu

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23. apr 2025, 10:00 UTC

Tulu

Thermo Fisher 1Q EPS $3.98 >TMO

Võrdlus sarnastega

Hinnamuutus

Thermo Fisher Scientific Inc Prognoos

Hinnasiht

By TipRanks

10.37% tõus

12 kuu keskmine prognoos

Keskmine 615.44 USD  10.37%

Kõrge 675 USD

Madal 561 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Thermo Fisher Scientific Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

20 ratings

17

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

406.5 / 417.79Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

74 / 373 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat